Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Tuberculosis (TB), one of the leading infectious disease killers ...

A recent international study found alarmingly high levels drug-resistant strains of tuberculosis (TB) in a number of countries. Researchers from the Centers for Disease Control and Prevention (CDC) ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

India, April 30 -- "Hello! I'm Deepti Chavan and I am an MDR-TB survivor. I know how it feels to hear the words ...

Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people each year and caused and estimated 1.25 million deaths in 2023. 1,2 While ...

They're being warned that "people may be sick for months before receiving a diagnosis, which can lengthen exposure periods" ...

More than 10 million people fall sick with tuberculosis (TB) every year. The disease remains the world’s biggest infectious disease killers with an estimated 1.25 million annual deaths. The disease is ...

A new study published in the American Society for Microbiology journal Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent ...

HONG KONG (Reuters) - Levels of drug-resistant tuberculosis (TB) in China are nearly twice the global average and almost 10 percent of cases are resistant to the most effective first-line drugs, a ...

An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...

Grants support discovery and development of novel drug candidates and evaluation and prioritization of advanced drug regimens for clinical testing New funding from the Gates Foundation extends ...